Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.907
+0.007 (0.72%)
At close: Nov 22, 2024, 4:00 PM
0.910
+0.003 (0.29%)
After-hours: Nov 22, 2024, 7:45 PM EST

Ocugen Revenue

Ocugen had revenue of $1.14M in the quarter ending September 30, 2024, a decrease of -69.29%. This brings the company's revenue in the last twelve months to $4.70M, down -33.94% year-over-year. In the year 2023, Ocugen had annual revenue of $6.04M with 142.60% growth.

Revenue (ttm)
$4.70M
Revenue Growth
-33.94%
P/S Ratio
50.66
Revenue / Employee
$72,308
Employees
65
Market Cap
264.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 2021---
Dec 31, 202043.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zynex 193.67M
Anika Therapeutics 164.17M
Poseida Therapeutics 150.86M
Lifecore Biomedical 128.44M
NeuroPace 76.45M
Precigen 3.96M
Artiva Biotherapeutics 2.60M
Atai Life Sciences 331.00K
Revenue Rankings